logo-loader
viewCommunisis

Communisis boss focused on growth after “good improvement” in 2015

Andy Blundell, chief executive of Communisis (LON:CMS) says he is seeing “good demand” for its integrated services, and says the firm is focused on delivering more growth and better free cash flow.

In its preliminary results for the year to December 31, the firm reported sales were up six per cent, operating profit up 20 per cent and net margin was ahead to 7.6 per cent on a constant currency basis.

Blundell says the firm is looking to offer more integrated services across the group, which are important to its existing clients, which include existing clients Barclays (LON:BARC), EE and Centrica (LON:CNA) as well as new customers Legal & General (LON:LGEN) and AXA.

Quick facts: Communisis

Price: - -

LSE:CMS
Market: LSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Genprex sees newly licensed diabetes gene therapy as an...

Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner tells Proactive the Texas-based biotech has signed a licensing agreement with the University of Pittsburgh for a diabetes gene therapy that could have the potential to treat Type 1 and Type 2 diabetes. Varner says the newly licensed diabetes gene...

2 days, 18 hours ago

2 min read